rs34729771
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000298854.7(RAPSN):c.691-11del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.61 ( 30441 hom., cov: 0)
Exomes 𝑓: 0.70 ( 351164 hom. )
Consequence
RAPSN
ENST00000298854.7 splice_polypyrimidine_tract, intron
ENST00000298854.7 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0750
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-47441931-AG-A is Benign according to our data. Variant chr11-47441931-AG-A is described in ClinVar as [Benign]. Clinvar id is 197249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-47441931-AG-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAPSN | NM_005055.5 | c.691-11del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000298854.7 | NP_005046.2 | |||
LOC124902673 | XR_007062669.1 | n.144+4166del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAPSN | ENST00000298854.7 | c.691-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_005055.5 | ENSP00000298854 | P1 | |||
RAPSN | ENST00000352508.7 | c.691-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000298853 | |||||
RAPSN | ENST00000529341.1 | c.691-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000431732 | |||||
RAPSN | ENST00000524487.5 | c.532-11del | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000435551 |
Frequencies
GnomAD3 genomes AF: 0.614 AC: 93335AN: 152042Hom.: 30426 Cov.: 0
GnomAD3 genomes
AF:
AC:
93335
AN:
152042
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.679 AC: 114250AN: 168348Hom.: 39600 AF XY: 0.693 AC XY: 63450AN XY: 91540
GnomAD3 exomes
AF:
AC:
114250
AN:
168348
Hom.:
AF XY:
AC XY:
63450
AN XY:
91540
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.703 AC: 989419AN: 1407860Hom.: 351164 Cov.: 0 AF XY: 0.706 AC XY: 491770AN XY: 696436
GnomAD4 exome
AF:
AC:
989419
AN:
1407860
Hom.:
Cov.:
0
AF XY:
AC XY:
491770
AN XY:
696436
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.614 AC: 93390AN: 152160Hom.: 30441 Cov.: 0 AF XY: 0.613 AC XY: 45596AN XY: 74396
GnomAD4 genome
AF:
AC:
93390
AN:
152160
Hom.:
Cov.:
0
AF XY:
AC XY:
45596
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2505
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 21, 2015 | - - |
Congenital Myasthenic Syndrome, Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Fetal akinesia deformation sequence 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 31, 2018 | - - |
Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Fetal akinesia deformation sequence 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Congenital myasthenic syndrome Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Congenital myasthenic syndrome 11 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at